Cardiologists, emergency medicine, critical care, and primary care physicians, in addition to other healthcare professionals involved in the diagnosis, management, and treatment of patients with heart failure.
Guideline-directed medical therapy; guidelines; heart failure (HF); heart failure with reduced ejection fraction (HFrEF); heart failure with preserved ejection fraction (HFpEF); therapy; medications; implementation; treatment initiation; treatment uptitration
Mohammad Shahzeb Khan, MD, MSc
Doctor
CV Institute, Baylor College of Medicine, Houston, Texas, USA.
Dr. Khan is an internationally recognized expert in cardiometabolic diseases and heart failure. He is currently the Physician Director of the Echocardiography School at the CV Institute, Baylor College of Medicine, Houston, Texas USA. He has authored and co-authored more than 400 peer-reviewed publications. He is involved in various pivotal clinical trials and is an associate editor of Heart Failure Reviews, ESC Heart Failure, and the Journal of Cardiac Failure - Intersections. Dr Khan is frequently invited to speak at national and international conferences on various cardiometabolic diseases and guideline-directed medical therapy. His work has been published in world’s most prestigious journals such as the New England Journal of Medicine, JAMA, Lancet, Nature Reviews Cardiology, Circulation, and the Journal of the American College of Cardiology. His research focuses on drug development and clinical trials of cardiometabolic therapies.Izza Shahid, MBBS
Doctor
Department of Cardiology, Houston Methodist Hospital, Houston (TX), USA
Dr. Izza Shahid is a postdoctoral research fellow in the Department of Cardiology at Houston Methodist Hospital (TX), USA. Her research focuses on cardiometabolic disease, heart failure, and preventive cardiology, with a particular emphasis on optimizing the use and intensification of guideline-directed medical therapy in heart failure. She has a special interest in evaluating the real-world effectiveness and implementation of therapeutic strategies in patients with cardiometabolic conditions.| 1. | Review the rationale for implementing high-intensity guideline-directed medical therapy (GDMT) across the full spectrum of ejection fraction in heart failure. |
| 1. | Review the rationale for implementing high-intensity guideline-directed medical therapy (GDMT) across the full spectrum of ejection fraction in heart failure. |
This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®).
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association physicians may convert EBAC® CE credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit.
To receive your CME certificate please complete the online evaluation, accessible via QR code, at the end of the activity.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Microsoft Edge Google Chrome 60 or higher Mozilla Firefox 60 or higher Apple Safari 11.0 or higher For video, install the latest version of Quicktime. | Supported Phones & Tablets: iOS 9.3 and higher Android 7.0 (Nougat or higher) Microsoft Windows 8 Chrome OS |
| Additional Recommendations and Requirements | |
| Display Resolution & Color Depth | Resolution - 960 X 768 minimum - 1024 X 768 recommended min. Color Depth - 8 bits (256 colors) minimum - 16 bits (High colors) minimum |
| Audio | - Microphone - Speakers or headphones - Audio recording support |
| Word Processing | Software that can open, modify, and save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are recommended. |